Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-08 4:15 pm Sale | 2024-01-04 | 13G | 4D Molecular Therapeutics, Inc. FDMT | VIKING GLOBAL INVESTORS LP | 4,247,914 9.900% | -540,000 (-11.28%) | Filing History |
| 2024-01-08 4:05 pm Purchase | 2023-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | VIKING GLOBAL INVESTORS LP | 4,787,914 11.200% | 850,000 (+21.59%) | Filing History |
| 2023-12-08 4:10 pm Purchase | 2023-12-06 | 13D | Cazoo Group Ltd CZOOF | VIKING GLOBAL INVESTORS LP | 21,427 43.800% | 21,427 (New Position) | Filing History |
| 2023-11-22 4:15 pm Unchanged | 2023-10-04 | 13D | Standard BioTools Inc. LAB | VIKING GLOBAL INVESTORS LP | 8,289,116 9.500% | 0 (Unchanged) | Filing History |
| 2023-11-22 4:15 pm Unchanged | 2023-07-18 | 13D | BridgeBio Pharma, Inc. BBIO | VIKING GLOBAL INVESTORS LP | 25,120,991 15.700% | 0 (Unchanged) | Filing History |
| 2023-11-22 4:15 pm Unchanged | 2023-11-03 | 13D | Cazoo Group Ltd CZOO | VIKING GLOBAL INVESTORS LP | 30,000 7.200% | 0 (Unchanged) | Filing History |
| 2023-11-07 4:10 pm Unchanged | 2023-11-03 | 13D | Cazoo Group Ltd CZOO | VIKING GLOBAL INVESTORS LP | 30,000 7.200% | 0 (Unchanged) | Filing History |
| 2023-11-02 4:30 pm Purchase | 2023-10-23 | 13G | Viking Therapeutics, Inc. VKTX | VIKING GLOBAL INVESTORS LP | 5,858,532 5.900% | 5,858,532 (New Position) | Filing History |
| 2023-10-16 4:30 pm Sale | 2023-10-04 | 13D | Standard BioTools Inc. LAB | VIKING GLOBAL INVESTORS LP | 8,289,116 9.500% | -34,705 (-0.42%) | Filing History |
| 2023-10-06 4:15 pm Purchase | 2023-09-26 | 13G | Five9, Inc. FIVN | VIKING GLOBAL INVESTORS LP | 3,647,595 5.100% | 3,647,595 (New Position) | Filing History |
| 2023-09-22 5:24 pm Unchanged | 2023-09-20 | 13D | Cazoo Group Ltd CZOO | VIKING GLOBAL INVESTORS LP | 30,000 7.200% | 0 (Unchanged) | Filing History |
| 2023-09-21 5:10 pm Purchase | 2023-09-19 | 13G | RayzeBio, Inc. Common Stock RYZB | VIKING GLOBAL INVESTORS LP | 6,642,700 10.900% | 6,642,700 (New Position) | Filing History |
| 2023-08-24 4:30 pm Purchase | 2023-08-14 | 13G | Valvoline Inc. VVV | VIKING GLOBAL INVESTORS LP | 8,338,456 6.000% | 8,338,456 (New Position) | Filing History |
| 2023-07-19 9:52 pm Sale | 2023-07-18 | 13D | BridgeBio Pharma, Inc. BBIO | VIKING GLOBAL INVESTORS LP | 25,120,991 15.700% | -1,500,000 (-5.63%) | Filing History |
| 2023-06-26 5:05 pm Sale | 2023-06-22 | 13G | Roivant Sciences Ltd. ROIV | VIKING GLOBAL INVESTORS LP | 75,238,700 9.900% | -13,000,000 (-14.73%) | Filing History |
| 2023-06-20 4:30 pm Purchase | 2023-06-07 | 13G | NewAmsterdam Pharma Company N.V. NAMS | VIKING GLOBAL INVESTORS LP | 6,524,565 7.980% | 6,524,565 (New Position) | Filing History |
| 2023-06-16 4:17 pm Unchanged | 2023-06-15 | 13D | Cazoo Group Ltd CZOO | VIKING GLOBAL INVESTORS LP | 30,000 7.200% | 0 (Unchanged) | Filing History |
| 2023-06-05 5:00 pm Purchase | 2023-05-26 | 13G | Verastem, Inc. VSTM | VIKING GLOBAL INVESTORS LP | 1,320,656 7.900% | 1,320,656 (New Position) | Filing History |
| 2023-05-16 5:27 pm Unchanged | 2023-05-12 | 13D | Cazoo Group Ltd CZOO | VIKING GLOBAL INVESTORS LP | 30,000 7.200% | 0 (Unchanged) | Filing History |
| 2023-04-27 4:30 pm Unchanged | 2023-04-25 | 13D | Cazoo Group Ltd CZOO | VIKING GLOBAL INVESTORS LP | 30,000 7.200% | 0 (Unchanged) | Filing History |